Every Form 4 that Baxter International Inc. (BAX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BAX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BAX filings page.
BAXTER INTERNATIONAL INC (BAX) reported a Form 4 for James Teaff, President, CCS. On September 1, 2026, 750 shares of common stock were withheld at $25.48 per share to pay tax liabilities arising from the settlement of vested restricted stock units granted on September 1, 2023. Following this tax-withholding disposition, Teaff directly held 30,370 shares, including shares from automatic dividend reinvestment and the Baxter Employee Stock Plan.
BAXTER INTERNATIONAL INC (BAX) reported that President and CEO Andrew P. Hider had 54,276 shares of common stock withheld on September 2, 2026 to cover taxes due from the settlement of vested restricted stock units granted on September 2, 2025, at a reference price of $25.70 per share. Following this tax-withholding disposition, he directly holds 518,447 shares of Baxter common stock, which total includes the automatic reinvestment of dividends; no Rule 10b5-1 trading plan is reported.
BAXTER INTERNATIONAL INC (BAX) reported that executive Julie Foster, President, Front Line Care, had 2,098 shares of common stock withheld on September 2, 2026 to cover tax obligations arising from the settlement of vested restricted stock units granted on September 2, 2025, at a reference price of $25.70 per share. After this tax-withholding transaction, Foster directly holds 29,164 shares of Baxter common stock, a figure that includes the automatic reinvestment of dividends. No transactions were reported as being made under a Rule 10b5-1 trading plan.
Zielinski Anita A reported acquisition or exercise transactions in this Form 4 filing.
Baxter International Inc. reported that senior vice president and interim CFO Anita A. Zielinski received a one-time special grant of 13,426 shares of common stock as a restricted stock unit award in connection with her additional duties. The award was granted at no cash cost to her and is scheduled to vest on the third anniversary of the grant date, subject to vesting requirements under Baxter’s Second Amended and Restated 2021 Incentive Plan. Following this equity grant and automatic reinvestment of dividends, she directly holds 59,714 shares of Baxter common stock.
Baxter International executive Steven P. Wallace reported a small share disposition related to taxes rather than a market trade. On June 2, 2026, 153 shares of common stock were forfeited to cover tax withholding triggered by the delivery of shares from vested restricted stock units.
These restricted stock units were originally granted on June 2, 2025 and settled one year later. After this tax-withholding disposition, Wallace directly holds 70,128 shares of Baxter common stock, so the event reflects routine compensation and payroll tax handling rather than an open-market sale.
Baxter International executive James Teaff reported a small, routine share disposition tied to taxes on equity compensation. On June 2, 2026, 321 shares of common stock were forfeited at $18.68 per share to cover withholding taxes from vested restricted stock units granted on June 2, 2025. After this tax-withholding event, Teaff directly holds 31,063 shares of Baxter common stock, including shares in the company’s Employee Stock Plan.
Wilkes David S. reported acquisition or exercise transactions in this Form 4 filing.
Baxter International Inc. director David S. Wilkes received a grant of 12,836 fully vested shares of common stock. The grant was recorded at a price of $0.00 per share, reflecting a share award rather than a market purchase. Following this award and automatic reinvestment of dividends, Wilkes now directly holds a total of 37,076 Baxter common shares.
Wendell Amy McBride reported acquisition or exercise transactions in this Form 4 filing.
Baxter International Inc. director Amy McBride received a grant of 12,836 fully vested shares of common stock. The shares were awarded at no purchase price as part of her compensation and are subject to the applicable grant terms and conditions.
After this award, McBride directly holds 44,235 Baxter shares, a total that includes the automatic reinvestment of dividends. This filing reflects a compensation-related share grant rather than an open-market purchase or sale.
SCHLICHTING NANCY M reported acquisition or exercise transactions in this Form 4 filing.
Baxter International Inc. director Nancy M. Schlichting reported an equity compensation grant of common stock. On May 5, 2026, she received 12,836 fully vested shares of Baxter common stock at a stated price of $0.00 per share, reflecting a grant or award rather than an open-market purchase. Following this grant, her direct holdings increased to 34,994 shares of common stock. The total reported share balance includes the automatic reinvestment of dividends.
MORRISON PATRICIA reported acquisition or exercise transactions in this Form 4 filing.
Baxter International Inc. director Patricia Morrison received a grant of 12,836 shares of common stock on May 5, 2026. The shares were fully vested at grant and awarded at no cash cost per share, as part of the company’s equity compensation. Following this award, she directly holds 42,386 Baxter common shares, a position that reflects both this grant and the automatic reinvestment of dividends.
Shafer David Brent reported acquisition or exercise transactions in this Form 4 filing.
Baxter International Inc. director and Chair of the Board David Brent Shafer received an equity grant of 12,836 fully vested shares of Baxter common stock. The shares were granted at no cash cost to him and are subject to the applicable grant terms and conditions.
Following this award, Shafer directly holds 72,804 Baxter common shares, a figure that includes shares added through the automatic reinvestment of dividends. This filing reflects a compensation-related stock grant rather than an open‑market purchase or sale.
McDonnell Michael R. reported acquisition or exercise transactions in this Form 4 filing.
Baxter International Inc. director Michael R. McDonnell received an equity grant of 12,836 shares of common stock. The award was fully vested when granted and is subject to the terms and conditions of the applicable grant. Following this compensation grant, he holds 14,647 common shares directly.
Craig Jeffrey A reported acquisition or exercise transactions in this Form 4 filing.
Baxter International director Jeffrey A. Craig received an equity grant of 12,836 shares of Baxter common stock on May 5, 2026. The shares were granted at no cost as fully vested stock, subject to the applicable grant terms. Following this award, Craig directly holds 23,662 shares, a figure that also reflects automatic reinvestment of dividends.
Ampofo William A. II reported acquisition or exercise transactions in this Form 4 filing.
Baxter International Inc. director William A. Ampofo II received a stock grant of 12,836 shares of common stock. The shares were granted at no cash cost to him as a fully vested award, increasing his directly held stake to 30,375 shares, including shares from automatic dividend reinvestment.
This Form 4 reflects a compensation-related grant, not an open-market purchase or sale, and does not indicate any change in his trading views on Baxter stock.
Baxter International senior vice president and chief accounting officer Anita A. Zielinski reported a routine tax-withholding transaction related to equity compensation. On March 6, 2026, 1,932 shares of common stock at $17.69 per share were forfeited to cover taxes from vested restricted stock units granted on March 6, 2025. After this withholding, she directly holds 46,281 Baxter shares.
Baxter International executive Maria Cecilia Soriano reported a routine tax-related share disposition. On March 6, 2026, 2,848 shares of common stock at $17.69 per share were forfeited to cover withholding taxes triggered by the delivery of shares from vested restricted stock units granted on March 6, 2024 and March 6, 2025. After this withholding transaction, she holds 75,045 Baxter shares directly.
Baxter International EVP and General Counsel David S. Rosenbloom had 6,620 shares of common stock withheld on March 6, 2026 to cover taxes arising from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. These shares were not sold in the open market but forfeited back to the company for tax-withholding purposes at a value of $17.69 per share. Following this routine tax-withholding disposition, he directly holds 138,216 shares of Baxter common stock.
Baxter International executive Reazur Rasul reported a routine tax-related share disposition. On March 6, 2026, 12,674 shares of common stock were forfeited to cover withholding taxes triggered by the settlement of previously granted restricted stock units. After this withholding, Rasul directly holds 125,557 Baxter shares.
Baxter International EVP and CFO Joel T. Grade reported a routine tax-withholding share disposition. On March 6, 2026, 8,153 shares of common stock at $17.69 per share were forfeited to cover taxes triggered by the settlement of vested restricted stock units, not through an open-market sale. After this withholding, he directly holds 271,674 shares.
Hider Andrew P. reported acquisition or exercise transactions in this Form 4 filing.
Baxter International President and CEO Andrew P. Hider reported awards of equity-based compensation. He received 488,506 stock options and 201,804 shares of common stock as a grant, both at a price of $0.00 per share. The stock grant consists of restricted stock units scheduled to vest in three equal annual installments beginning on March 1, 2027, subject to vesting conditions under Baxter’s 2021 Incentive Plan. The options become exercisable on the same three-year schedule starting March 1, 2027.
Carlisle Cynthia reported acquisition or exercise transactions in this Form 4 filing.
Baxter International reported that Executive Vice President and CHRO Cynthia Carlisle received new equity awards. She was granted stock options for 43,103 shares, which become exercisable in three equal annual installments beginning on March 1, 2027. She also received 17,806 restricted stock units scheduled to vest in three equal annual installments beginning on March 1, 2027, and an additional 11,871 restricted stock units scheduled to vest on February 27, 2029, all subject to vesting conditions under the company’s 2021 Incentive Plan.
Baxter International executive Reazur Rasul reported a tax-related share disposition. On March 2, 2026, 1,614 shares of common stock at $19.69 per share were forfeited to cover withholding taxes triggered by the settlement of vested restricted stock units granted on March 1, 2023. After this tax-withholding disposition, Rasul directly owned 138,231 Baxter shares.
Baxter International executive Maria Cecilia Soriano reported equity compensation changes involving common stock and options. On February 27, 2026, she acquired 23,742 shares of common stock at $0.00 per share as a grant, and received a stock option award covering 57,471 shares, also at $0.00 per share. These restricted stock units and options are scheduled to vest or become exercisable in three equal annual installments beginning on March 1, 2027, subject to the vesting requirements of Baxter’s 2021 Incentive Plan. On March 2, 2026, she disposed of 1,852 shares of common stock at $19.69 per share to cover taxes due on previously vested restricted stock units, leaving her with 77,894 common shares directly held.
Baxter International EVP and General Counsel David S. Rosenbloom reported equity compensation changes and related tax withholding. On February 27, 2026 he received 26,709 shares of common stock and a grant of 64,655 stock options, both at $0.00 per share as awards scheduled to vest in three equal annual installments beginning on March 1, 2027 under Baxter’s 2021 Incentive Plan. On March 2, 2026, 1,336 common shares at $19.69 per share were forfeited to cover taxes from the settlement of previously vested restricted stock units. After these transactions he directly owned 144,837 common shares and 64,655 stock options.
Grade Joel T. reported acquisition or exercise transactions in this Form 4 filing.
Baxter International executive vice president and CFO Joel T. Grade reported equity awards rather than open-market trades. He received stock options for 103,448 shares at a price of $0.0000 per share and a grant of 42,735 shares of common stock.
The common stock grant represents restricted stock units scheduled to vest in three equal annual installments beginning on March 1, 2027, subject to the vesting conditions in Baxter’s 2021 Incentive Plan. The options become exercisable in three equal annual installments starting on the same date. Following these grants, Grade directly holds 279,828 common shares, including shares in the employee stock plan.
Zielinski Anita A reported acquisition or exercise transactions in this Form 4 filing.
Baxter International senior vice president, chief accounting officer and controller Anita A. Zielinski reported receiving an equity award of 30,864 shares of common stock in the form of restricted stock units at a stated price of $0.00 per share. These units are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to the vesting conditions in Baxter’s 2021 Incentive Plan. After this award and dividend reinvestments, Zielinski now directly holds 48,214 shares of Baxter common stock.
McDonnell Michael R. reported acquisition or exercise transactions in this Form 4 filing.
Baxter International director Michael R. McDonnell reported receiving a grant of 1,811 shares of Baxter common stock. The shares were granted at a price of $0.0000 per share and are described as fully vested, subject to the applicable grant terms and conditions. Following this award, McDonnell holds 1,811 shares of Baxter common stock directly.
Baxter International executive Maria Cecilia Soriano reported equity compensation activity. On February 9, 2026, she acquired 2,273 shares of Baxter common stock at $0.00 per share through the vesting of performance share units granted on March 1, 2023.
On the same date, 918 shares were disposed of at $21.73 per share to cover tax withholding triggered by this vesting. After these transactions, she directly beneficially owned 56,006 shares of Baxter common stock, a figure that includes automatic dividend reinvestments.
Baxter International executive David S. Rosenbloom, EVP and General Counsel, reported equity compensation activity. On February 9, 2026, he acquired 17,055 shares of Baxter common stock at $0 from a performance share unit award granted March 1, 2023, which vested after a three-year performance period ending December 31, 2025.
On the same date, 5,225 shares were forfeited at $21.73 to cover taxes from this vesting. After these transactions, he directly owned 119,464 Baxter shares, a figure that includes automatic dividend reinvestments.
Baxter International executive Reazur Rasul reported equity compensation activity. On February 9, 2026, he acquired 18,951 shares of Baxter common stock at $0.00 per share, issued upon vesting of performance share units granted under the company’s 2021 Incentive Plan and 2023 performance share program.
To satisfy tax withholding from this vesting, 5,770 shares were automatically withheld and disposed of at $21.73 per share. After these transactions, Rasul directly owned 139,846 shares of Baxter common stock, which total includes shares from automatic dividend reinvestment.
Baxter International executive Joel T. Grade reported equity award activity involving company stock. On February 9, 2026, he acquired 30,504 shares of Baxter common stock at $0 per share from vested 2023 performance share units tied to multi-year sales, TSR, and ROIC goals.
On the same date, 9,144 shares were withheld at $21.73 per share to cover taxes from this vesting. After these transactions, Grade directly held 236,904 Baxter shares, including amounts from dividend reinvestment and the employee stock plan.
Baxter International executive Jeanne K. Mason, EVP and Chief HR Officer, reported an insider share forfeiture. On 12/12/2025 she forfeited 650 shares of Baxter common stock at $19.15 per share to cover Federal Insurance Contributions Act (FICA) taxes on restricted stock unit awards previously granted under Baxter International Inc.'s Long-Term Incentive Plan. After this tax withholding transaction, she beneficially owns 199,853 Baxter shares, and this total includes the automatic reinvestment of dividends.